- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
Highlights
- Market Cap
- $2.14M
- Enterprise Value
- $6.40M
- EPS (TTM)
- -$0.00
- EBITDA (TTM)
- -$239.99K
- Year Range
- $0.00 - $0.00
- ROA (TTM)
- -59,291.00%
- ROE (TTM)
- 6.35%
- Avg. Volume (1M)
- 8M
- Avg. Volume Value (1M)
- $3.88K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
VXIT Performance Chart
VirExit Technologies, Inc. (VXIT) is down 33.3% since the beginning of the year. At $0 per share, VXIT is trading 76.0% below its 52-week high of $0. Investors who bought $1,000 worth of VXIT shares 5 years ago would now be looking at an investment worth $56.
Loading charts...
Compare this symbol against anything
Returns By Period
VirExit Technologies, Inc. (VXIT) has returned -33.33% so far this year and 36.36% over the past 12 months.
VirExit Technologies, Inc.
- 1D
- 29.03%
- 1M
- 0.00%
- 6M
- -63.64%
- YTD
- -33.33%
- 1Y
- 36.36%
- 3Y*
- -5.01%
- 5Y*
- -43.80%
- 10Y*
- —
- ALL TIME*
- -52.09%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
VXIT Monthly Returns History
Based on dividend-adjusted daily data since Jan 28, 2019, VXIT's average daily return is +1.22%, while the average monthly return is +9.79%. At this rate, an investment would double in approximately 0.6 years.
Historically, 38% of months were positive and 62% were negative. The best month was Feb 2021 with a return of +539.5%, while the worst month was Jun 2019 at -81.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 10 months.
On a daily basis, VXIT closed higher 33% of trading days. The best single day was Jun 5, 2020 with a return of +450.0%, while the worst single day was Nov 14, 2019 at -66.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 83.33% | 30.30% | -11.63% | -5.26% | -55.56% | -33.12% | 12.15% | -33.33% | |||||
| 2025 | 50.00% | 33.33% | -25.00% | 0.00% | 50.00% | -44.44% | -20.00% | 25.00% | -0.00% | -20.00% | -10.00% | 150.00% | 125.00% |
| 2024 | 0.00% | 33.33% | 0.00% | 12.50% | 11.11% | 90.00% | -21.05% | -33.33% | 10.00% | -27.27% | -50.00% | 0.00% | -33.33% |
| 2023 | 13.04% | -16.23% | -49.49% | -27.27% | -31.25% | 9.09% | 16.67% | 28.57% | 11.11% | -20.00% | -12.50% | -14.29% | -73.91% |
| 2022 | 104.26% | -12.50% | -14.29% | -13.89% | -16.13% | 23.08% | -9.38% | -0.00% | -12.07% | -1.96% | 96.00% | -53.06% | -2.13% |
| 2021 | 83.75% | 539.46% | -62.77% | -0.00% | -30.00% | -45.51% | -19.85% | -25.23% | -25.00% | -23.33% | -16.30% | -38.96% | -70.62% |
Benchmark Metrics
VirExit Technologies, Inc. has an annualized alpha of 1820.64%, beta of 0.71, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since January 28, 2019.
- This stock participated in 16.24% of S&P 500 Index downside but only -116.45% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 1,820.64%
- Beta
- 0.71
- R²
- 0.00
- Upside Capture
- -116.45%
- Downside Capture
- 16.24%
Return for Risk
Risk / Return Rank
VXIT ranks 67 for risk / return — above 67% of stocks peers on PortfoliosLab. Its historical combined result is above most peers.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for VirExit Technologies, Inc. (VXIT) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VXIT | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.18 | ||
| Sortino ratioReturn per unit of downside risk | +0.10 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.25 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.57 | 2.00 | -1.43 |
| Martin ratioReturn relative to average drawdown | 1.30 | 8.49 | -7.19 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the VirExit Technologies, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the VirExit Technologies, Inc. was 99.94%, occurring on Nov 22, 2019. The portfolio has not yet recovered.
The current VirExit Technologies, Inc. drawdown is 99.60%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.94%Nov 2019 | 9mo 28d | — | 7y 6moJan 2019 - now | — |
Drawdown Indicators
| VXIT | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.94% | -56.78% | -43.16% |
Max Drawdown (1Y)Largest decline over 1 year | -87.50% | -9.10% | -78.40% |
Max Drawdown (3Y)Largest decline over 3 years | -87.50% | -18.90% | -68.60% |
Max Drawdown (5Y)Largest decline over 5 years | -97.40% | -25.43% | -71.97% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.60% | -1.58% | -98.02% |
Average DrawdownAverage peak-to-trough decline | -96.74% | -10.70% | -86.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 38.43% | 2.14% | +36.29% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of VirExit Technologies, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how VirExit Technologies, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with VXIT
Add VirExit Technologies, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with VXIT